Heart Sense is entering into Regional Phase of IP
We are proud to announce that Heart Sense technology has entered into Regional Phase of Intellectual Property Protection in target markets.
Patent Application has been successfully applied in EU (EPO), USA, CANADA, INDIA, BRASIL, AUSTRALIA, JAPAN, SOUTH KOREA.These markets represent regions were vast majority of global amount of cardiac surgical procedures are being performed.
This process was coordinated by Patent Attorneys from SDP Sierzant&Dudzinski and Heart Sense Board.